Involvement of apoptosis in the cardioprotective effect of volatile anesthetics
Involvement of apoptosis in the cardioprotective effect of volatile anesthetics
批准号:
18592210
负责人:
MIYAMAE Masami
金额:
$2.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
1.抗凋亡蛋白Akt是否参与了七氟烷的心肌保护作用?已有研究表明,异氟醚诱导的心肌预适应依赖于磷脂酰肌醇-3-激酶(PI3K)/Akt信号通路,而磷脂酰肌醇-3-激酶(PI3K)/Akt信号转导通路在再灌注损伤挽救激酶级联反应中起中心作用。目前尚不清楚这一信号级联是否参与了七氟醚诱导的预适应。灌流豚鼠离体心30min,再灌流120min(CTL)。七氟醚(1MAC;2%)给药10min,于缺血前冲洗10min,可诱导七氟醚预适应。蛋白印迹法检测Akt蛋白的磷酸化。缺血再灌注后,SEVO较CTL有更高的左心室发育和更低的舒张末压力。与CTL相比,SEVO组的梗塞面积显著缩小。在缺血和再灌流10min后,AKT的磷酸化水平没有增加,这与Find…相反在异氟醚诱导的预适应中,有更多的ING被证实。结论:1.在七氟醚诱导的预适应过程中,丝裂原活化蛋白激酶/细胞外信号调节激酶(MEK)和细胞外信号调节激酶(ERK)等抢救性信号通路在再灌注损伤中可能发挥更重要的作用。在乙醇和七氟醚诱导的预适应之间是否存在相互作用?我们研究了七氟醚是否增强了乙醇预适应,以及蛋白激酶C(PKC)和线粒体KATP通道的抑制是否减弱了这种增强的心脏保护作用。体外灌流豚鼠心脏,全心缺血30min,再灌注120min(对照组:CTL)。乙醇组(Etoh)在饮用水中加入2.5%乙醇,连续6周。麻醉预适应由七氟醚(1MAC;2%)在乙醇(Etoh+Sevo)或非乙醇(Sevo)心脏中暴露10min引起。白屈菜红碱(ChE)和5-羟基癸酸(5-HD)分别抑制PKC通道和线粒体KATP通道。缺血再灌注后,无水乙醇、七氟醚(Sevo)和无水乙醇+七氟醚(SEVO)组较CTL组LVdP升高,LVEDP降低。与CTL相比,Etoh和Sevo组心肌梗死面积缩小。七氟醚进一步缩小了无水乙醇心脏的梗塞面积。CHE和5-HD取消了Sevo和Etoh心脏保护心脏的心脏保护作用。无水乙醇心脏iNOS表达减少,eNOS表达增加。七氟醚可增强常规乙醇消耗诱导的心脏预适应。这种作用部分是通过调节PKC和线粒体K_(t;t;ATP>)通道,以及可能通过改变NOS的表达来实现的。较少
英文摘要
1. Is Akt, antiapoptotic kinase, involved in the cardioprotective effect of sevoflurane ?It has been reported that isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase (PI3K)/Akt signaling which plays a central role of reperfusion injury salvage kinase cascade. It remains unclear whether this signaling cascade is involved in sevoflurane-induced preconditioning. Isolated perfused guinea pig hearts underwent 30 min global ischemia and 120 min reperfusion (CTL). Sevoflurane-induced preconditioning was elicited by administration of 10 min of sevoflurane (1 MAC; 2%) with 10 min washout before ischemia (SEVO). Phosphorylation of Akt was assessed by western blot. After ischemia-reperfusion, SEVO had higher left ventricular developed and lower end-diastolic pressure versus CTL. Infarct size was significantly reduced in SEVO compared to CTL. Akt phosphorylation was not increased during ischemia and 10 min after reperfusion, which is in contrast to the find … More ings previously demonstrated in isoflurane-induced preconditioning. Other reperfusion injury salvage kinases such as mitogen-activated protein kinase/extracellular signal-regulated kinases (MEK) and extra-cellular signal-regulated kinase (ERK) may be more important in sevoflurane-induced preconditioning.2. Is there any interaction between ethanol-and sevoflurane-induced preconditioning ?We investigated whether sevoflurane enhances ethanol preconditioning and whether inhibition of protein kinase C (PKC) and mitochondrial KATP channels attenuated this enhanced cardioprotection. Isolated perfused guinea pig hearts underwent 30 min global ischemia and 120 min reperfusion (Control: CTL). The ethanol group (EtOH) received 2.5% ethanol in their drinking water for 6 weeks. Anesthetic preconditioning was elicited by 10 min exposure to sevoflurane (1 MAC; 2%) in ethanol (EtOH+SEVO) or non-ethanol (SEVO) hearts. PKC and mitochondrial KATP channels were inhibited with chelerythrine (CHE) and 5-hydroxydecanoate (5-HD) pretreatment, respectively. After ischemia-reperfusion, EtOH, sevoflurane (SEVO), and EtOH+SEVO groups had higher LVDP and lower LVEDP compared with CTL. Infarct size was reduced in EtOH and SEVO hearts compared with CTL. Sevoflurane further reduced infarct size in EtOH hearts. CHE and 5-HD abolished cardioprotection in both SEVO and EtOH cardioprotected hearts. iNOS expression was reduced and eNOS expression was increased in EtOH hearts. Sevoflurane enhances cardiac preconditioning induced by regular EtOH consumption. This effect is mediated in part by modulation of PKC and mitochondrial K_<ATP> channels, and possibly by altered modulation of NOS expression. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
セボフルランによる急性プレコンディショニングの心筋保護効果は1時間以内に消失する
七氟醚急性预处理的心肌保护作用在1小时内消失
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Uchihashi T, et. al., 高橋 直之, Sun W, Sun W, J Sato, K Kaneyama, Kaneyama K., Kaneyama K, Kaneyama K, J Sato, K Fujimura, Fujimura K., K Fujimura, 金田 一弘, 稲村 吉高, KANEDA K., 金田 一弘, 大草 知佳]
通讯作者:
大草 知佳
Sevoflurane preconditioning does not diminish phosphorylation of P38MAPK and MAPKAPK2 during sustained ischemia.
七氟烷预处理不会减少持续缺血期间 P38MAPK 和 MAPKAPK2 的磷酸化。
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Uchihashi T, et. al., 高橋 直之, Sun W, Sun W, J Sato, K Kaneyama, Kaneyama K., Kaneyama K, Kaneyama K, J Sato, K Fujimura, Fujimura K., K Fujimura, 金田 一弘, 稲村 吉高, KANEDA K., 金田 一弘, 大草 知佳, 大草 知佳, OKUSA C., OKUSA C., OKUSA C., SUGIOKA S.]
通讯作者:
SUGIOKA S.
Involvement of Akt in sevoflurane-induced Attenuation of cardiac ischemia-reperfusion injury
Akt 参与七氟烷诱导的心肌缺血再灌注损伤的减轻
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Uchihashi T, et. al., 高橋 直之, Sun W, Sun W, J Sato, K Kaneyama, Kaneyama K., Kaneyama K, Kaneyama K, J Sato, K Fujimura, Fujimura K., K Fujimura, 金田 一弘, 稲村 吉高, KANEDA K.]
通讯作者:
KANEDA K.
Sevoflurane enhances ethanol-induced cardiac preconditioning through mitochondrial K^<ATP> channels and Protein Kinase C activation in guinea pig hearts
七氟醚通过线粒体 K^<ATP> 通道和蛋白激酶 C 激活增强豚鼠心脏中乙醇诱导的心脏预处理
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Uchihashi T, et. al., 高橋 直之, Sun W, Sun W, J Sato, K Kaneyama, Kaneyama K., Kaneyama K, Kaneyama K, J Sato, K Fujimura, Fujimura K., K Fujimura, 金田 一弘, 稲村 吉高, KANEDA K., 金田 一弘, 大草 知佳, 大草 知佳, OKUSA C., OKUSA C., OKUSA C., SUGIOKA S., 金田 一弘, KANEDA K.]
通讯作者:
KANEDA K.
Anesthetic preconditoning by 2% sevoflurane is lost within 1 hr after a brief exposure in isolated guinea pig hearts.
麻醉%20预处理%20by%202%%20七氟烷%20is%20lost%20内%201%20hr%20后%20a%20brief%20暴露%20in%20隔离%20几内亚%20猪%20心。
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Uchihashi T, et. al., 高橋 直之, Sun W, Sun W, J Sato, K Kaneyama, Kaneyama K., Kaneyama K, Kaneyama K, J Sato, K Fujimura, Fujimura K., K Fujimura, 金田 一弘, 稲村 吉高, KANEDA K., 金田 一弘, 大草 知佳, 大草 知佳, OKUSA C., OKUSA C.]
通讯作者:
OKUSA C.
共 12 条
The role of autophagy in cardioprotection by volatile anesthetics
-
批准号:23593008
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:MIYAMAE Masami
-
依托单位:
The mechanisms of enhanced cardioprotection by combination of volatile anesthetics and moderate alcohol consumption
-
批准号:20592382
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:MIYAMAE Masami
-
依托单位:
Signal transduction in the cardioprotective effect of volatile anesthetics
-
批准号:16592032
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:MIYAMAE Masami
-
依托单位:
Signal Transduction in the Cardioprotective Effect of Light Alcohol and its clinical application for ischemic preconditioning
-
批准号:12670706
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.77万
-
财政年份:2000
-
负责人:MIYAMAE Masami
-
依托单位:
Signal Transduction in the Cardioprotective Effect of Alcohol
-
批准号:10670683
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1998
-
负责人:MIYAMAE Masami
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: